/
BCRX
$9.74-$0.07 (-0.71%)live
Held by
1
portfolio on TandT
Bookmarked by
0
users
Avg position size
8.6%
of holders' portfolios
13F filers
2
institutions
Market cap
$2.7B
256M shares
52-week range
$6.00 – $11.22
72% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-5.53
BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
www.biocryst.com- Employees
- 435
- IPO / List date
- Mar 3, 1994
- HQ
- DURHAM, NC
Held by traders on TradeandTell
| Trader / Portfolio | Conviction |
|---|---|
| July PortfolioShkreli | Mild9% |
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 776,990 | $7.4M |
Recent trades on TradeandTell
- 7/10/2026in July Portfolio →
